Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.38
+0.26 (1.84%)
At close: Apr 28, 2026, 4:00 PM EDT
14.21
-0.17 (-1.21%)
After-hours: Apr 28, 2026, 6:27 PM EDT
Vor Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 43.48 | 27.88 | 31.72 | 28.87 | 21.49 | |
| Research & Development | 298.46 | 93.31 | 94.32 | 64.55 | 47.53 | |
| Operating Expenses | 341.94 | 121.19 | 126.04 | 93.42 | 69.02 | |
| Operating Income | -341.94 | -121.19 | -126.04 | -93.42 | -69.02 | |
| Interest & Investment Income | 5.87 | 4.27 | 8.17 | 1.32 | 0.12 | |
| Other Non Operating Income (Expenses) | -334.36 | - | - | - | - | |
| EBT Excluding Unusual Items | -670.43 | -116.91 | -117.86 | -92.09 | -68.9 | |
| Merger & Restructuring Charges | -29.71 | - | - | - | - | |
| Gain (Loss) on Sale of Assets | 4.15 | - | - | - | - | |
| Pretax Income | -695.98 | -116.91 | -117.86 | -92.09 | -68.9 | |
| Net Income | -695.98 | -116.91 | -117.86 | -92.09 | -68.9 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 1.23 | |
| Net Income to Common | -695.98 | -116.91 | -117.86 | -92.09 | -70.13 | |
| Shares Outstanding (Basic) | 10 | 3 | 3 | 2 | 2 | |
| Shares Outstanding (Diluted) | 10 | 3 | 3 | 2 | 2 | |
| Shares Change (YoY) | 187.35% | 2.26% | 69.88% | 18.30% | 15547.86% | |
| EPS (Basic) | -70.50 | -34.03 | -35.08 | -46.57 | -41.95 | |
| EPS (Diluted) | -70.50 | -34.03 | -35.08 | -46.57 | -41.95 | |
| Free Cash Flow | -143.65 | -99.89 | -101.36 | -93.61 | -73.04 | |
| Free Cash Flow Per Share | -14.55 | -29.07 | -30.17 | -47.33 | -43.69 | |
| EBITDA | -339.05 | -117.66 | -122.54 | -90.89 | -67.58 | |
| D&A For EBITDA | 2.89 | 3.53 | 3.49 | 2.53 | 1.43 | |
| EBIT | -341.94 | -121.19 | -126.04 | -93.42 | -69.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.